179
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Urban–Rural disparities in status of hypertension in northeast China: a population-based study, 2017–2019

, , , , , , , , & show all
Pages 801-820 | Published online: 03 Sep 2019

References

  • Collaborators GBDRF. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1659–1724. doi:10.1016/S0140-6736(16)31679-8.27733284
  • Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390:2549–2558. doi:10.1016/S0140-6736(17)32478-929102084
  • Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;72:1201–1210. doi:10.1016/j.jacc.2018.06.05630189996
  • Satoh A, Arima H, Ohkubo T, et al.; Group NDR. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens. 2017;35:401–408. doi:10.1097/HJH.000000000000116928005709
  • Li Z, Guo X, Zheng L, Yang H, Sun Y. Grim status of hypertension in rural China: results from Northeast China rural cardiovascular health study 2013. J Am Soc Hypertens. 2015;9:358–364. doi:10.1016/j.jash.2015.02.01425863573
  • Yan R, Li W, Yin L, Wang Y, Bo J; Investigators PU-C. Cardiovascular diseases and risk-factor burden in urban and rural communities in high-, middle-, and low-income regions of China: a large community-based epidemiological study. J Am Heart Assoc. 2017;6:e004445. doi:10.1161/JAHA.116.00444528167497
  • Wang W, Jiang B, Sun H, et al.; Investigators NE-C. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480,687 adults. Circulation. 2017;135:759–771. doi:10.1161/CIRCULATIONAHA.116.02525028052979
  • Wu Y, Huxley R, Li L, et al. China NSC and China NWG. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–2686. doi:10.1161/CIRCULATIONAHA.108.78816619106390
  • Zhang FL, Guo ZN, Xing YQ, Wu YH, Liu HY, Yang Y. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey. J Hum Hypertens. 2017;32:54–65. doi:10.1038/s41371-017-0003-429180804
  • Zhang Y, Moran AE. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736–742. doi:10.1161/HYPERTENSIONAHA.117.0980128847890
  • Booth JN 3rd, Li J, Zhang L, Chen L, et al. Trends in prehypertension and hypertension risk factors in US adults: 1999–2012. Hypertension. 2017;70:275–284. doi:10.1161/HYPERTENSIONAHA.116.0900428607131
  • Joshi SR, Shah SN. Control of blood pressure in India: rule of halves still very much valid. J Assoc Physicians India. 2003;51:151–152.12725256
  • Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China health and retirement longitudinal study. Bull World Health Organ. 2014;92:29–41. doi:10.2471/BLT.13.12449524391298
  • Lu Y, Wang P, Zhou T, et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc. 2018;7:e007462. doi:10.1161/JAHA.118.00852829374046
  • Xing L, Liu S, Tian Y, et al. Trends in status of hypertension in rural northeast China: results from two representative cross-sectional surveys, 2013–2018. J Hypertens. 2019;28:1400–1408.
  • Xing L, Jing L, Tian Y, et al. High prevalence of stroke and uncontrolled associated risk factors are major public health challenges in rural northeast China: a population-based study. Int J Stroke. 2019;May 15. doi:10.1177/1747493019851280
  • Liu LS, Gao RL, Chen WW, et al. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579–615.22088239
  • Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–1324. doi:10.1161/HYP.000000000000006629133354
  • Yan L, Xu MT, Yuan L, et al. Prevalence of dyslipidemia and its control in type 2 diabetes: a multicenter study in endocrinology clinics of China. J Clin Lipidol. 2016;10:150–160. doi:10.1016/j.jacl.2015.10.00926892132
  • Chamberlain JJ, Rhinehart AS, Shaefer CF Jr., Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2016;164:542–552. doi:10.7326/M15-301626928912
  • Wang J, Ning X, Yang L, et al. Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991–2011. J Hum Hypertens. 2014;28:25–31. doi:10.1038/jhh.2013.4423739160
  • Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist-hip ratio. Eur J Clin Nutr. 2010;64:2–5. doi:10.1038/ejcn.2009.13919935820
  • Collaborators GBDM. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1084–1150. doi:10.1016/S0140-6736(17)31833-028919115
  • Huang X, Zhou Z, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension among China’s Sichuan Tibetan population: a cross-sectional study. Clin Exp Hypertens. 2016;38:457–463. doi:10.3109/10641963.2016.116336927359364
  • Li J, Shi L, Li S, Xu L, Qin W, Wang H. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese adults from 1993 to 2011. Int J Equity Health. 2017;16:50. doi:10.1186/s12939-017-0545-728288635
  • Wang Z, Chen Z, Zhang L, et al.; China Hypertension Survey I. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137:2344–2356. doi:10.1161/CIRCULATIONAHA.117.03238029449338
  • Chobanian AV, Bakris GL, Black HR, et al.; National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P and National High Blood Pressure Education Program Coordinating C. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572. doi:10.1001/jama.289.19.256012748199
  • Rahman M, Zaman MM, Islam JY, et al. Prevalence, treatment patterns, and risk factors of hypertension and pre-hypertension among Bangladeshi adults. J Hum Hypertens. 2018;32:334–348. doi:10.1038/s41371-017-0018-x29230005
  • Piaditis G, Markou A, Papanastasiou LA II, Kaltsas G. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2015;172:R191–R203. doi:10.1530/EJE-14-053725538205
  • Kanegae H, Oikawa T, Kario K. Should pre-hypertension be treated? Curr Hypertens Rep. 2017;19:91. doi:10.1007/s11906-017-0789-z29046988
  • Khera R, Lu Y, Lu J, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ. 2018;362:k2357. doi:10.1136/bmj.k235729997129
  • Scheltens T, Bots ML, Numans ME, et al. Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21:99–106. doi:10.1038/sj.jhh.100212317136106
  • Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3:e003423. doi:10.1136/bmjopen-2013-003423
  • Reynolds K, Gu D, Muntner P, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21:1273–1281. doi:10.1097/01.hjh.0000059043.65882.1512817173
  • Chow CK, Teo KK, Rangarajan S, et al.; investigators PS. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–968. doi:10.1001/jama.2013.18418224002282
  • Agyemang C, Nyaaba G, Beune E, et al. Variations in hypertension awareness, treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians living in rural and urban Ghana – the RODAM study. J Hypertens. 2018;36:169–177. doi:10.1097/HJH.000000000000152028858173
  • Wu J, Li T, Song X, et al. Prevalence and distribution of hypertension and related risk factors in Jilin Province, China 2015: a cross-sectional study. BMJ Open. 2018;8:e020126. doi:10.1136/bmjopen-2017-020126
  • statistics PsRoCNBo. People’s Republic of China 2015 National Economic and Social Development Statistical Bulletin People’s Daily. 2016-03-01:010.
  • Barker-Collo S, Bennett DA, Krishnamurthi RV, et al.; Group GBDW and Group GBDSPE. Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the global burden of disease study 2013. Neuroepidemiology. 2015;45:203–214. doi:10.1159/00044110326505984